Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody

NCT07285213 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

230

Enrollment

INDUSTRY

Sponsor class

Conditions

Clostridioides Difficile Infection

Interventions

DRUG: AZD5148
OTHER: Placebo

Sponsor

AstraZeneca